I’m thrilled to share that I have successfully defended my dissertation thesis!
My research focused on developing a novel therapeutic strategy using genetically modified oncolytic measles viruses to target cancer cells. By engineering the virus to express a full-length antibody against CD47, I aimed to both directly destroy tumor cells and reprogram the tumor microenvironment to support anti-tumor immune responses. The project combined molecular biology, immunology, and virology – and I’m incredibly proud of the scientific and personal journey this represents.
This milestone marks the completion of my medical doctoral studies, and I’m looking forward to the next chapter in research and innovation.
Thank you to everyone who supported me along the way!